Katzmann Breast Tumor Boards

Clive, IA US
June 19, 2024

Purpose

To review current cancer cases. Presentations will include pathology, radiology, pharmacology, and other pertinent material to the case under discussion.

Target Audience

Healthcare providers who work at MercyOne Katzmann Breast Care.

Learning Objectives

  • Explain multidisciplinary care for breast cancer patients.
  • Discuss findings involved in breast care.
  • Compose a treatment plan for breast cancer, including National Comprehensive Cancer Network® (NCCN) guidelines.

Facilitator(s)

Tiffany Torstenson, DO, FACOS
Medical Director, Breast Surgical Oncologist, MercyOne Katzmann Breast Care

Dr. Torstenson finished her general surgery residency at MercyOne Des Moines Medical Center. She went on to a breast surgical oncology fellowship at Mayo Clinic in Rochester, Minnesota. Dr. Torstenson is actively involved in numerous clinical trials and greatly advocates these for her patients. She has multiple publications and speaking appearances. She is skilled in ultrasonography, and her focus is oncoplastic breast surgery and nipple-sparing mastectomy. She is actively involved in the surgical education of the residents in the general surgery program at MercyOne Des Moines Medical Center.

Course summary
Available credit: 
  • 1.00 AOA Category 1­A
Course opens: 
06/19/2024
Course expires: 
06/19/2024
Event starts: 
06/19/2024 - 7:00am CDT
Event ends: 
06/19/2024 - 8:00am CDT
Cost:
$0.00
Rating: 
0
MercyOne Katzmann Breast Care
1601 NW 114th St.
Clive, IA 50325
United States

Accreditation Statements

  • DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

EDUCATIONAL GRANTS

No ineligible company provided financial support for this continuing education activity. 

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.

Relevant to the content of this educational activity, the following individuals have no conflict(s) with ineligible companies to disclose.

  • Susan Beck, DO, FACOS - Activity Director and Planning Committee Member
  • Devon Foster, DO - Planning Committee Member
  • Melani Walford, RN, BSN - Planning Committee Member
  • Katlyn Wood, RN, BSN - Activity Coordinator and Planning Committee Member

Relevant to the content of this educational activity, the following individual(s) have conflict(s) with ineligible companies to disclose. All relevant financial relationships have been mitigated.

  • Tiffany Torstenson, DO, FACOS - Planning Committee Member and Moderator
    • Consultant - Eli Lilly and Company

DISCLAIMER

The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition. 

Available Credit

  • 1.00 AOA Category 1­A

Price

Cost:
$0.00
Please login or Create an Account to take this course.